US equities
|
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SPCX
$147.49
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NU
$15.16
▲+0.00%
NVDA
$210.96
▲+0.00%
NBIS
$158.74
▲+0.00%
AAPL
$347.73
▲+0.00%
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SPCX
$147.49
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NU
$15.16
▲+0.00%
NVDA
$210.96
▲+0.00%
NBIS
$158.74
▲+0.00%
AAPL
$347.73
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Corcept Therapeutics Incorporated - Common Stock
(NQ:
CORT
)
85.86
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corcept Therapeutics Incorporated - Common Stock
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Corcept Shareholder Alert
January 28, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Investor Alert
January 25, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT)
January 25, 2022
From
Robbins LLP
Via
Business Wire
Corcept Investor Alert
January 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Notice
January 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Investor Alert
January 11, 2022
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Corcept To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Corcept Update
December 24, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Corcept To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Corcept Shareholder Notice
December 23, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Corcept To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Corcept Shareholder Alert
January 17, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Alert
January 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Alert
January 07, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Alert
January 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Investor Alert
January 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Alert
December 31, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Notice
December 16, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Corcept To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
CORCEPT INVESTOR ALERT
December 14, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Corcept To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Corcept Shareholder Alert
December 28, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Investor Alert
December 27, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Shareholder Alert
December 22, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Corcept Investor Alert
December 21, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Inc. on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm
December 14, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Why Corcept Therapeutics Stock Was Up 11.6% Friday
↗
December 10, 2021
Investors may be looking for a bargain after the company was hit with bad news this week.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 10, 2021
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 23.65% to $2.81 during Friday's regular session. As of 12:30 EST, BioLine Rx's stock is trading at a...
Via
Benzinga
Why Corcept Therapeutics Tanked by Almost 17% Today
↗
December 08, 2021
A U.S. attorney is interested in the company for the wrong reasons.
Via
The Motley Fool
Topics
Law Enforcement
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 08, 2021
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's...
Via
Benzinga
52 Biggest Movers From Yesterday
↗
December 09, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares surged 84.1% to close at $19.11 on Wednesday. Insignia Systems recently announced the commencement of a formal process to...
Via
Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
↗
December 08, 2021
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options...
Via
Benzinga
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
↗
November 03, 2021
CORT earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
↗
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
↗
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
